Insider Shareholders with Direct Ownership of Gossamer Bio, Inc. (GOSS)
This section provides a comprehensive overview of the insiders with direct ownership of Gossamer Bio, Inc. (GOSS). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Gossamer Bio, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Waage Christian
EVP, Tech Ops and Admin |
45,000 | 22,642 | 585,934 $568,355 | 4 |
Mar 27, 2024
Reduced 1.09%
|
Luisa Salter Cid
Chief Scientific Officer |
45,000 | 5,491 | 206,065 $199,883 | 2 |
Mar 23, 2021
Reduced 2.6%
|
Richard Aranda
Chief Medical Officer |
15,000 | 30,493 | 196,891 $190,984 | 9 |
Jun 24, 2024
Reduced 0.96%
|
Faheem Hasnain
President & CEO |
162,500 | 42,207 | 120,293 $116,684 | 3 |
Mar 27, 2024
Reduced 16.15%
|
Bryan Giraudo
COO/CFO |
45,000 | 22,642 | 92,737 $89,954 | 4 |
Mar 27, 2024
Reduced 6.48%
|
Laura Carter
Chief Scientific Officer |
42,754 | 28,354 | 76,263 $73,975 | 9 |
Mar 16, 2023
Reduced 7.33%
|
Caryn Peterson
EVP, Regulatory Affairs |
10,820 | 24,995 | 49,833 $48,338 | 6 |
Mar 18, 2024
Reduced 7.46%
|